Alex K Blankenship - Net Worth and Insider Trading

Alex K Blankenship Net Worth

The estimated net worth of Alex K Blankenship is at least $7,700 dollars as of 2024-05-27. Alex K Blankenship is the President and CEO of GlobeStar Therapeutics Corp and owns about 11,000,000 shares of GlobeStar Therapeutics Corp (GSTC) stock worth over $7,700. Details can be seen in Alex K Blankenship's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alex K Blankenship has not made any transactions after 2020-08-14 and currently still holds the listed stock(s).

Transaction Summary of Alex K Blankenship

To

Alex K Blankenship Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alex K Blankenship owns 1 companies in total, including GlobeStar Therapeutics Corp (GSTC) .

Click here to see the complete history of Alex K Blankenship’s form 4 insider trades.

Insider Ownership Summary of Alex K Blankenship

Ticker Comapny Transaction Date Type of Owner
GSTC GlobeStar Therapeutics Corp 2020-08-14 director & CEO & Pres. & Secr. & Treas.

Alex K Blankenship Latest Holdings Summary

Alex K Blankenship currently owns a total of 1 stock. Alex K Blankenship owns 11,000,000 shares of GlobeStar Therapeutics Corp (GSTC) as of August 14, 2020, with a value of $7,700.

Latest Holdings of Alex K Blankenship

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GSTC GlobeStar Therapeutics Corp 2020-08-14 11,000,000 0.00 7,700

Holding Weightings of Alex K Blankenship


Alex K Blankenship Form 4 Trading Tracker

According to the SEC Form 4 filings, Alex K Blankenship has made a total of 1 transactions in GlobeStar Therapeutics Corp (GSTC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in GlobeStar Therapeutics Corp is the acquisition of 11,000,000 shares on August 14, 2020, which cost Alex K Blankenship around $6.5 Billion.

Insider Trading History of Alex K Blankenship

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alex K Blankenship Trading Performance

GuruFocus tracks the stock performance after each of Alex K Blankenship's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alex K Blankenship is 212.5%. GuruFocus also compares Alex K Blankenship's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alex K Blankenship within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alex K Blankenship's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alex K Blankenship

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 139.58
Relative Return to S&P 500(%) 139.26

Alex K Blankenship Ownership Network

Ownership Network List of Alex K Blankenship

No Data

Ownership Network Relation of Alex K Blankenship


Alex K Blankenship Owned Company Details

What does GlobeStar Therapeutics Corp do?

Who are the key executives at GlobeStar Therapeutics Corp?

Alex K Blankenship is the director & CEO & Pres. & Secr. & Treas. of GlobeStar Therapeutics Corp. Other key executives at GlobeStar Therapeutics Corp include director & CEO James C Katzaroff , CFO Robert Chicoski , and 10 percent owner Brent Atwood .

GlobeStar Therapeutics Corp (GSTC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GlobeStar Therapeutics Corp (GSTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GlobeStar Therapeutics Corp (GSTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GlobeStar Therapeutics Corp (GSTC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

GlobeStar Therapeutics Corp Insider Transactions

No Available Data

Alex K Blankenship Mailing Address

Above is the net worth, insider trading, and ownership report for Alex K Blankenship. You might contact Alex K Blankenship via mailing address: 14001 Walden Rd., Suite 600, Montgomery Tx 77356.

Discussions on Alex K Blankenship

No discussions yet.